GlaxoSmithKline agrees to USD20 million penalty with SEC for FCPA violations | Practical Law

GlaxoSmithKline agrees to USD20 million penalty with SEC for FCPA violations | Practical Law

The SEC has announced its agreement to accept an offer to settle charges against GlaxoSmithKline that its China-based subsidiaries violated the internal controls and record keeping provisions of the FCPA.

GlaxoSmithKline agrees to USD20 million penalty with SEC for FCPA violations

Practical Law UK Legal Update w-003-8922 (Approx. 3 pages)

GlaxoSmithKline agrees to USD20 million penalty with SEC for FCPA violations

by Practical Law China
Law stated as at 12 Oct 2016 • China
The SEC has announced its agreement to accept an offer to settle charges against GlaxoSmithKline that its China-based subsidiaries violated the internal controls and record keeping provisions of the FCPA.